# Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer

> **NCT07021911** · — · RECRUITING · sponsor: **Fondazione Policlinico Universitario Campus Bio-Medico** · enrollment: 300 (estimated)

## Conditions studied

- Breast Cancer
- Radiotherapy; Complications

## Interventions

- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT07021911
- **Lead sponsor:** Fondazione Policlinico Universitario Campus Bio-Medico
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-17
- **Primary completion:** 2029-05-17
- **Final completion:** 2029-05-17
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07021911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07021911, "Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT07021911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*